Mackenzie Financial Corp Bio Techne Corp Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

A detailed history of Mackenzie Financial Corp transactions in Bio Techne Corp stock. As of the latest transaction made, Mackenzie Financial Corp holds 2,854,665 shares of TECH stock, worth $209 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

2,854,665

Previous 2,862,260 0.27%

Holding current value

$209 Million

Previous $205 Million 11.23%

% of portfolio

0.34%

Previous 0.32%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$70.96 - $82.35 $538,941 - $625,448	-7,595 Reduced 0.27%	2,854,665 $228 Million
Q2 2024 Aug 14, 2024	BUY	$62.12 - $84.15 $13.4 Million - $18.2 Million	216,044 Added 8.16%	2,862,260 $205 Million
Q1 2024 May 10, 2024	BUY	$65.98 - $77.09 $16.3 Million - $19 Million	246,889 Added 10.29%	2,646,216 $186 Million
Q4 2023 Jan 30, 2024	BUY	$52.83 - $78.22 $3.71 Million - $5.5 Million	70,294 Added 3.02%	2,399,327 $185 Million
Q3 2023 Oct 25, 2023	BUY	$67.52 - $89.42 $13.5 Million - $17.9 Million	200,032 Added 9.4%	2,329,033 $159 Million
Q2 2023 Aug 03, 2023	BUY	$73.76 - $85.98 $20.2 Million - $23.6 Million	274,048 Added 14.77%	2,129,001 $174 Million
Q1 2023 Apr 24, 2023	BUY	$71.62 - $86.62 $6.29 Million - $7.61 Million	87,838 Added 4.97%	1,854,953 $138 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $109 Million - $478 Million	1,356,899 Added 330.78%	1,767,115 $146 Million
Q3 2022 Oct 07, 2022	BUY	$282.54 - $391.85 $6.84 Million - $9.49 Million	24,219 Added 6.27%	410,216 $117 Million
Q2 2022 Aug 10, 2022	BUY	$322.67 - $449.65 $31.9 Million - $44.4 Million	98,729 Added 34.37%	385,997 $134 Million
Q1 2022 May 13, 2022	BUY	$353.85 - $487.79 $101 Million - $139 Million	284,741 Added 11267.95%	287,268 $124 Million
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $49,264 - $56,706	-108 Reduced 4.1%	2,527 $1.31 Million
Q3 2021 Nov 08, 2021	BUY	$444.87 - $538.88 $497,809 - $603,006	1,119 Added 73.81%	2,635 $1.28 Million
Q2 2021 Aug 11, 2021	BUY	$387.35 - $450.26 $587,222 - $682,594	1,516 New	1,516 $683,000
Q3 2018 Nov 15, 2018	SELL	$147.44 - $204.11 $611,876 - $847,056	-4,150 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$144.9 - $165.58 $12 Million - $13.7 Million	-82,791 Reduced 95.23%	4,150 $614,000
Q1 2018 May 14, 2018	SELL	$131.46 - $151.04 $44.7 Million - $51.4 Million	-340,065 Reduced 79.64%	86,941 $13.1 Million
Q4 2017 Feb 13, 2018	SELL	$121.17 - $134.75 $17.4 Million - $19.3 Million	-143,295 Reduced 25.13%	427,006 $55.3 Million
Q3 2017 Nov 13, 2017	SELL	$113.59 - $123.78 $5.1 Million - $5.56 Million	-44,886 Reduced 7.3%	570,301 $68.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	615,187	615,187 $72.3 Million

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.87B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Bio Techne Corp Transaction History